Cargando…
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
With the intent to identify biomarkers in renal cell carcinoma (RCC) the functional status of T-regulatory cells (Tregs) was investigated in primary RCC. Tregs were isolated from tumoral-(TT), peritumoral tissue-(PT) and peripheral blood-(PB) of 42 primary RCC patients and function evaluated through...
Autores principales: | Santagata, Sara, Napolitano, Maria, D'Alterio, Crescenzo, Desicato, Sonia, Maro, Salvatore Di, Marinelli, Luciana, Fragale, Alessandra, Buoncervello, Maria, Persico, Francesco, Gabriele, Lucia, Novellino, Ettore, Longo, Nicola, Pignata, Sandro, Perdonà, Sisto, Scala, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652768/ https://www.ncbi.nlm.nih.gov/pubmed/29100374 http://dx.doi.org/10.18632/oncotarget.20363 |
Ejemplares similares
-
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
por: Trotta, Anna Maria, et al.
Publicado: (2018) -
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
por: Santagata, Sara, et al.
Publicado: (2017) -
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
por: D’Alterio, Crescenzo, et al.
Publicado: (2019) -
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
por: Neve Polimeno, Maria, et al.
Publicado: (2015) -
Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015)